UvA-DARE is a service provided by the library of the University of Amsterdam (http://dare.uva.nl)

UvA-DARE (Digital Academic Repository)

Transmyocardial laser revascularisation. Clinical experience in patients with refractory anginapectoris

van der Sloot, J.A.P.

Link to publication

Citation for published version (APA):van der Sloot, J. A. P. (2003). Transmyocardial laser revascularisation. Clinical experience in patients withrefractory angina pectoris.

General rightsIt is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s),other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons).

Disclaimer/Complaints regulationsIf you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, statingyour reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Askthe Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam,The Netherlands. You will be contacted as soon as possible.

Download date: 02 Jun 2020

References s

1.. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. CirculationCirculation 2001;104:365-72

2.. Henderson AH. Coronary heart disease: Overview. Lancet 1996;348 (Suppl I):s 1 -4 3.. Management of stable angina pectoris: Recommendations of the Task Force of the

Europeann Society of Cardiology. Eur Heart J 1997;18:394-413 4.. Epstein SE, Quyyumi AA, Bonow RO. Myocardial ischemia: Silent or symptomatic.

MewMew Engi J Med i 988;318: i 038-43 5.. Klein J, Chao SY, Berman DS, Rozanski A. Is 'silent' myocardial ischemia really as

severee as symptomatic ischemia? The analytical effect of patient selection biases. CirculationCirculation 1994;89:1958-66

6.. Heberden W. Some account of a disorder of the breast. Med Trans R Coil Phys (London)(London) 1772;2:59-67

7.. ACC / AHA Task Force on practice guidelines (Committee on the management of patientss with chronic stable angina). ACC/AHA/ACP-ASIM guidelines for the managementt of patients with chronic stable angina. Circulation 1999;99:2829-48

8.. Heart disease. A textbook of cardiovascular medicine. Braunwald E, Zipes DP, Libby P.. Eds. WD Saunders company, Philadelphia, 2003

9.. Kaski JC\ Elliot PM. Angina pectoris and normal coronary arteriograms: clinical presentationn and hemodynamic characteristics. Am J Cardiol 1995;76:D35-42

10.. Kaski JC. Chest pain and normal coronary arteriograms: role of "microvascular spasm".. Lancet 1998;351:1144-5

11.. Mannheimer C, Camici P, Chester MR, Collins A, de Jongste M, Eliasson T, Follath F, Hellemanss I, Hcrlitz J, Luscher T, Pasic M. Thelle D. The problem of refractory angina.. £i/r Heart./2002;23:355-70

12.. Cardiovascular disease in the Netherlands 2003. Annual report of The Netherlands HeartHeart Foundation 2003

13.. Mukherjee D, Bhatt DL. Roe MT, Patel V, Ellis SG. Direct myocardial revascularizationn and angiogencsis - How many patients might be eligible? Am J CardiolCardiol 1999;84:598-600

14.. Brorsson B, Persson H. Landelius P, Werkö L. Smartor i bröstet: Operation. ballongvidgning,, medicinsk behandling. Stockholm, Sweden: Statens heredningför utvarderingutvardering av medicinsk metod'tk 1998;Report No: 140

15.. Mannheimer C. Therapeutic challenges of refractory angina. In: XXth Congress of the Europeann Society of Cardiology: 1998. Vienna, Austria

16.. Meyer BJ. Amann FW. Additional antianginal efficacy of amiodarone in patients with limitingg angina pectoris. Am Heart J 1993;125:996-1001

17.. Scandinavian simvastatin survival study group. Randomised trial of cholesterol loweringg in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survivall Study (4S). Lancet 1994;344:1383-9

18.. Ridker PM, Manson JE, Gaziano JM, Buring JE, Hcnnekens CH. Low-dose aspirin therapyy for chronic stable angina. A randomized, placebo-controlled clinical trial. Ann IntInt Med 1991:114:835-9

19.. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelett therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelett therapy in various categories of patients. Br Med J 1994;308:81-106

-- 135-

References References 20.. Beta-blocker pooling project research group. The Beta-Blocker Pooling Project

(BBPP):: subgroup findings from randomized trials in post infarction patients, Eur HeartHeart J 1988:9:8-16

21.. Gruntzig A. Transluminal dilatation of coronary-artery stenosis. Lancet 1978:1:263 22.. Bowers TR, Stewart RE. O'Neill WW. Reddy VM, Safian RD. Effect of Rotablator

atherectomyy and adjunctive balloon angioplasty on coronary blood flow. Circulation 1997:95:1157-64 4

23.. Appelman. YEA. Excimer laser angioplasty compared to balloon angioplasty. Dissertationn 1996. University of Amsterdam

24.. Ilia R. Kolanski D, Setaro J, Brennan J. Cabin H, Cleman M, Remetz M. Percutaneous transluminall coronary angioplasty in unstable and stable angina pectoris: A comparisonn of immediate success and complications. Cardiology 1992:81:245-50

25.. Sousa JR. Scrruys PW. Costa MA. New Frontiers in Cardiology: Drug-Eluting Stents: Partt I. Circulation 2003;107:2274-9

26.. Sousa JE, Serruys PW, Costa MA. New Frontiers in Cardiology: Drug-Eluting Stents: Partt II. Circulation 2003:107:2383-9

27.. Benetti F, Patel AN. Hamman B. Indications for off-pump coronary surgery. J CardiovascCardiovasc Surg 2003;44:319-22

28.. Gersh BJ, Califf RM, Loop FD, Akins CW, Pryor DB. Takaro TC. Coronary bypass surgeryy in chronic stable angina. Circulation 1989;7:146-59

29.. Goldman S. Copeland J, Moritz T. Internal mammary artery and saphenous vein graft patency.. Effects of aspirin. Circulation 1990;82 (Suppl IV):237-42

30.. RITA trialists. Coronary angioplasty versus coronary artery bypass surgery: The Randomizedd Intervention Treatment of Angina (RITA) trial. Lancet 1993:341:573-80

31.. Hamm CW, Reimers J, Ischinger T, Rupprecht HJ. Berger J. Bleifeld W. A randomizedd study of coronary angioplasty compared with bypass surgery in patients withh symptomatic multi-vessel coronary disease. German Angioplasty Bypass surgery Investigationn (GABI). New Engl J Med 1994;331:1037-43

32.. The BARI (Bypass Angioplasty Revascularization Investigation) Investigators. Comparisonn of coronary bypass surgery with angioplasty in patients with multi-vessel disease.. New Engl J Med 1996;335:217-25

33.. Crea F, Pupita G, Galassi A, El-Tamimi H. Kaskt JC, Davies G. Maseri A. Role of adenosinee in pathogenesis of angina pain. Circulation 1990;81:164-72

34.. Meller ST. Gebhart GF. A critical review of the afferent pathways and the potential chemicall mediators involved in cardiac pain. Neuroseience 1992;48:501-42

35.. Kennard MA. Haugen FP. The relation of subcutaneous focal sensitivity to referred painn of cardiac origin. Anesthesiology 1955:16:297

36.. Mannheimer C. Carlsson CA, Vedin A, Wilhelmsson C. Transcutaneous electrical nervee stimulation (TENS) in angina pectoris. Pain 1986;26:291-300

37.. Melzack R. Wall PD. Pain mechanisms: A new theory. Science 1965;150:971-9 38.. Jessurun GAJ, DeJongste M, Blanksma PK.. Current views on neurostimulation in the

treatmentt of cardiac ischemic syndromes. Pain 1996;66:109-16 39.. Hautvast RWM, DeJongste MJL, Staal MJ, van Gilst WH, Lie KI. Spinal cord

stimulationn in chronic intractable angina pectoris: A randomized, controlled efficacy study.. Am Heart J 1998; 136:1114-20

40.. Eliasson T, Augustinsson L-E. Mannheimer C. Spinal cord stimulation in severe anginaa pectoris - presentation of current studies, indications and clinical experience. PainPain 1996;65:169-79

-136 --

41.. Heart Association Task Force on practice guidelines. ACC / AHA guidelines for coronaryy artery bypass graft surgery. J Am Coll Cardiol 1999;34:1262-347

42.. Mannheimer C, Eliasson T. Augustinsson L-E, Blomstrand C, Emanuelsson H. Larssonn S, Norrsell H, Hjalmarsson A. Electrical stimulation versus coronary artery bypasss surgery in severe angina pectoris; The ESBY study. Circulation 1998;97:1157-63

43.. ACC / AHA Task Force on practice guidelines (Committee on the management of patientss with chronic stable angina). ACC7AHA 2002 guideline update for the managementt of patients with chronic stable angina - summary article. Circulation 2002;107:149-58 8

44.. Blomberg S. Curelaru I, Emanuelsson H, Herlitz J. Ponten J, Ricksten SE. Thoracic epidurall anesthesia in patients with unstable angina pectoris. Eur Heart J 1989;10:437-44

45.. Gramling-Babb P, Miller M, Reeves S, Roy R, Zile M. Treatment of medically and surgicallyy refractory angina pectoris with high thoracic epidural analgesia: Initial clinicall experience. Am Heart J 1997;133:648-55

46.. Wiener L, Cox W. Influence of stellate ganglion block on angina pectoris and the post-exercisee electrocardiogram. Am J Med Sci 1966;252:289-95

47.. Hammond C, Leach A, Chester M. Temporary sympathectomy for refractory angina. BrBr Med J \999;H\ (Suppl I): 19

48.. Wetterwik C. Claes G, Drott C. Endoscopic transthoracic sympathicotomy for severe angina.. Lancet 1995;345:97-8

49.. Beck CS. The development of a new blood supply to the heart by operation. Ann Surg 1935;102:801-13 3

50.. Vineberg A. Clinical and experimental studies in the treatment of coronary artery insufficiencyy by internal mammary artery implant. J Int Coll Surg 1954;22:503-18

55 1. Vineberg A. Evidence that revascularization by ventricular-internal mammary artery implantss increases longevity. Twenty-four year, nine month follow-up. J Thome CardiovascCardiovasc Surg 1975;70:381 -97

52.. Waern J, Mettier S, Klumpp T, Zschiesche L. The nature of the vascular communicationss between the coronary arteries and the chambers of the heart. Am HeartHeart J 1933;9:143-64

53.. Sen P, Udwadia T, Kinare S. Parulkar G. Transmyocardial revascularization: A new approachh to myocardial revascularization. J Thome Cardiovasc Surg 1965;50:181-9

54.. Kohmoto T, Argenziano M, Yamamoto N, Vliet KA, Gu A, Derosa CM, Fisher PE, Spotnitzz HM, Burkhoff D. Smith CR. Assessment of transmyocardial perfusion in alligatorr hearts. Circulation 1997;95:1585-91

55.. O'Connor WN, Cash JB, Cottrill CM, Johnson GL, Noonan JA. Ventriculocoronary connectionss in hypoplastic left hearts: An autopsy microscopic study. Circulation 1982:66:1078-86 6

56.. Bonnet D, Gautier-Lhermitte I, Bonhoeffer P, Sidi D. Right ventricular myocardial sinusoidal-coronaryy artery connections in critical pulmonary valve stenosis, Ped CardiolCardiol 1998;19:269-71

57.. Goldman A, Greenstone SM, Preuss FS, Strauss SH, Chang ES. Experimental methods forr producing a collateral circulation to the heart directly from the left ventricle../ ThomeThome Surg 1956;31:364-74

58.. Massimo C. Boffi L. Myocardial revascularization by anew method of carrying blood directlyy from the left ventricular cavity into the coronary circulation. J Thome Surg 1957;34:257-64 4

-- 137-

References References 59.. Hershcy JE, White M. Transmyocardial puncture revascularization. A possible

emergencyy adujet to arterial implant surgery. Geriatrics 1969:24:101-8 60.. Pifarrc R. Jasuja M. Lynch R. Neville W. Myocardial revascularization by

transmyocardiall acupuncture: A physiologic impossibility. J Thorac Cardiovasc Surg 1969;58:424-31 1

61.. Leschke M, Schoebel F-C, Mecklenbeck W, Stein D, Jax TW. Müller-Gartner H-W. Straucrr B-E. Long-term intermittent urokinase therapy in patients with end-stage coronaryy artery disease and refractory angina pectoris: A randomized dose-response trial.. J Am Coil Cardiol 1996;27:575-84

62.. Urano H, Ikeda J, Ueno T, Matsumoto T. Murohara T, Imaizumi T. Enhanced external counterpulsationn improves exercise tolerance, reduces exercise-induced myocardial ischemiaa and anginal episodes. J,Am Coll Cardiol 2001;37:93-9

63.. Folkman J. Tumor angiogenesis: A possible control point in tumor growth. Ann Intern MedMed 1975:82:96-100

64.. Schumacher B, Pecher P, von Specht BU. Stegmann T. Induction of neoangiogenesis inn ischemic myocardium by human growth factors: First clinical results of a new treatmentt of coronary heart disease. Circulation 1998;97:645-50

65.. Isner JM, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T. Rosenfield K, Razvi S.. Walsh K, Symes JF. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF1655 in patients with ischaemic limbs. Lancet 1996;348:370-4

66.. van Roven, N. Therapeutic arteriogenesis: From experimental observations towards clinicall application. Dissertation 2003. University of Amsterdam

67.. Mirhoseini M, Cayton MM. Revascularization of the heart by laser. J Microsurg 1981;2:253-60 0

68.. Mirhoseini M. Fisher JC, Cayton M. Myocardial revascularization by laser: A clinical report.. Lasers Surg Med 1983;3:241-5 '

69.. Huikeshoven M. Beck JF, van der Sloot JAP. Tukkie R, van der Meulen J, van Gemert MJC.. 35 Years of experimental research in transmyocardial laser revascularization: Whatt have we learned? Ann Thorac Surg 2002;74:956-70

70.. van der Wouw PA. van der Sloot JAP, van der Meulen J, Tukkie R, Beek JF. Transmyocardiall laser channels. J Am Soc Echocardiog 1998; 11:986-8

71.. March RJ. Transmyocardial laser revascularization with the CO: laser: One year resultss of a randomized, controlled trial. Semin Thorac Cardiovasc Surg 1999:11:12-8

72.. Allen KB, Dowling RD, Fudge TL, Schoettle GP. Selinger SL, Gangahar DM, Angell WW,, Petracek MR. Shaar CJ, O'Neill WW. Comparison of transmyocardial revascularizationn with medical therapy in patients with refractory angina. New Engl J MedMed 1999;341:1029-36

73.. Burkhoff D, Schmidt S, Schulman SP, Myers J, Resar J, Becker LC, Weiss, Jones JW. Transmyocardiall laser revascularisation compared with continued medical therapy for treatmentt of refractory angina pectoris: A prospective randomised trial. Lancet 1999;354:885-90 0

74.. Frazier OH, March RJ. Horvath KA. Transmyocardial revascularization with a carbon dioxidee laser in patients with end-stage coronary artery disease. New EnglJ Med 1999;341:1021-8 8

75.. Schofteld PM. Sharpies LD. Caine N, Burns S. Tait S, Wistow T, Wallwork J. Transmyocardiall laser revascularisation in patients with refractory angina: A randomisedd controlled trial. Lancet 1999:353:519-24

-138--

76.. Aaberge L, Nordstrand K. Dragsund M, Saatvedt K. Endresen K, Golf S, Geiran O, Abdelnoorr M, Forfang K. Transmyocardial revascularization with C02 laser in patients withh refractory angina pectoris - clinical results from the Norwegian randomized trial. JJ Am Coll Cardiol 2000;35:1170-7

77.. Spertus JA, Jones PG. Coen M. Garg M, Bliven B. O'Keefe J. March RJ, Horvath K. Transmyocardiall CO; laser revascularization improves symptoms, function, and qualityy of life: 12-Month results from a randomized controlled trial. Am J Med 2001;111:341-8 8

78.. Fuchs S, Baffour R. Vodovotz Y. Shou M. Stabile F., Tin FO, Leon MB, Komcwski R. Laserr myocardial revascularization modulates expression of angiogenic, neuronal, and inflammatoryy cytokines in a porcine model of chronic myocardial ischemia. J Card SurgSurg 2002;17:413-24

79.. Li W, Tanaka K, Chiba Y, Kimura T, Moroika K, Uesaka T. Ihaya A7 Sasaki M, Tsuda T,, Yamada N. Role of MMPs and plasminogen activators in angiogenesis after transmyocardiall laser revascularization in dogs. Am J Phvsiol - Heart Circ Physiol 2003;284:1123-30 0

80.. Hughes GC. Biswas SS. Yin B. Baklanov DV, Annex BH, Coleman RE. DeGrado TR. Landolfoo CK, Landotfo KP, Lowe JE. A comparison of mechanical and laser transmyocardiall revascularization for induction of angiogenesis and arteriogenesis in chronicallyy ischemic myocardium. J Am Coll Cardiol 2002;39:1220-8

81.. Meerkin D, Pellerin M. Aretz HT, Paiement P, Houser SL, Bonan R. Transmyocardial coill implants: A novel approach to transmyocardial revascularization. Ann Thome SurgSurg 2002;74:488-92

82.. Lutter G. Attmann T. Heilmann C, von Samson P, von Specht BU, Beyersdorf F. The combinedd use of transmyocardial laser revascularization (TMLR) and fibroblastic growthh factor (FGF-2) enhances perfusion and regional contractility in chronically ischemicc porcine hearts. Eur J Cardiothorac Surg 2002;22:753-61

83.. Heilmann CA, Attmann T, von Samson P, Gobel H. Marme D, Beyersdorf F, Lutter G. Transmyocardiall laser revascularization combined with vascular endothelial growth factorr 121 (VEGF121) gene therapy for chronic myocardial ischemia-do the effects reallyy add up? Eur J Cardiothorac Surg 2003;23:74-80

84.. Sylven C. Neurophysiological aspects of angina pectoris. Z Kardiol 1997;86:95-105 85.. Barber MJ. Mueller TM, Davies BG. Zipes DP. Phenol topically applied to canine left

ventricularr epicardium interrupts sympathetic but not vagal afferents. Circ Res 1984;55:532-44 4

86.. Olausson K, Magnusdottir H, Lurje L, Wennerblom B, Emanuelsson H, Rickstcn SE, Anti-isehemicc and anti-anginal effects of thoracic epidural anesthesia versus those of conventionall medical therapy in the treatment of severe refractory unstable angina pectoris.. Circulation 1997;96:2178-82

87.. Al-Sheikh T. Allen KB, Straka SP. Heimansohn DA, Fain RL, Hutchins GD, Sawada SG,, Zipes DP. Engelstein ED. Cardiac sympathetic denervation after transmyocardial laserr revascularization. Circulation 1999;100:135-40

88.. Muxi A, Magrina J. Martin F. Josa M, Fuster D, Setoain FJ. Perez-Villa F, Pavia J. Boschh X. Technetium 99m-labeled tetrofosmin and iodine 123-labeled metaiodobenzylguanidinee scintigraphy in the assessment of transmyocardial laser revascularization.. J Thorac Cardiovasc Surg 2003;125:1493-8

-- 139-

References References 89.. Kadipasaoglu KA. Pehlivanoglu S, Conger JL, Sasaki E, de Villalobos DU, Cloy M,

Piluikoo V. Clubb FJJ. Cooley DA, Frazier OH. Long- and short-term effects of transmyocardiall laser revascularization in acute myocardial ischemia. Lasers Surg Med 1997:20:6-14 4

90.. Horvath KA, Greenee R. Belkind N, Kane B, McPherson DD, Fullerton DA. Left ventricularr functional improvement after transmyocardial laser revascularization. Ann ThoracThorac Surg 1998;66:721-5

91.. Mueller XM Tevacarai HT, Genton CY, von Segesser LK. Myocardial scarring after transmyocardiall laser revascularization: A potential mechanism of clinical improvement?? Lasers Surg Med 1999;25:79-87

92.. Whittaker P, Kloner RA. Transmural channels as a source of blood How to ischemic myocardium?? Insights from the reptilian heart. Circulation 1997;95:1357-9

93.. Transmyocardial laser revascularisation; Management of coronary artery diseases. Kleinn M. Schulte HD and Gams E. Eds. Springer, Berlin. 1998

94.. Horvath KA, Mannting F, Cummings N, Shernan SK, Cohn Li) . Transmyocardial laser revascularization:: Operative techniques and clinical results at two years../ Thorac Caniiova.seCaniiova.se Surg 1996; 111:1047-53

95.. Cooley DA, Frazier OH, Kadipasaoglu KA, Lindenmeir MH, Pehlivanoglu S, Kolff JW,, Wilansky S, Moore WH. Transmyocardial laser revascularization: Clinical experiencee with twelve-month follow-up. J Thorac Cardiovasc Surg 1996;! 11:791-7

96.. Thrush DN. Anesthesia for laser transmyocardial revascularization. J Cardiolhorac VascAnesthVascAnesth 1997;11:481-4

97.. von Knobclsdorff G, Brauer P. Tonner PH, Hanel F. Naegale H. Stubbe HM, Esch JS. Transmyocardiall laser revascularization induces cerebral microembolization. AnesthesiologyAnesthesiology 1997;87:58-62

98.. Whittaker P. Transmyocardial revascularization: The fate of myocardial channels. Ann ThoracThorac Surg 1999;68:2376-82

99.. Kwong KF, Kancllopoulos GK, Nickols JC, Pogwizd SM. Saffitz JE, Schuessler RB. Sundtt TM3. Transmyocardial laser treatment denervates canine myocardium. J Thorac CardiovascCardiovasc Surg 1997; 114:883-9

100.. Spanier T, Smith CR, Burkhoff D. Angiogenesis: A possible mechanism underlying thee clinical benefits of transmyocardial laser revascularization. J Clin Laser Med Surg 1997;15:269-73 3

101.. Burkhoff D, Fisher PE, Apfelbaum M. Kohmoto T, Derosa CM, Smith CR. Histologic appearancee of transmyocardial laser channels after 4 1/2 weeks. Ann Thorac Surg 1996;61:1532-4 4

302.. Krabatsch T, Schaper F. Leder C, Tulsner J, Thalmann U, Hetzer R. Histological findingss after transmyocardial laser revascularization. J Cardiac Surg 1996; 11:326-31

103.. Gassier N, Wintzer HO, Stubbe HM, Wullbrand A, Helmchen U. Transmyocardial laserr revascularization. Histological features in human nonresponder myocardium. CirculationCirculation 1997;95:373-5

104.. Domkowski PW. Biswas SS, Steenbergen C, Lowe JE. Histological evidence of angiogenesiss 9 months after transmyocardial laser revascularization. Circulation 2001:103:469-71 1

105.. Mirhoseini M, Shelgikar S. Cayton MM. Clinical and histological evaluation of laser myocardiall revascularization. J Clin Laser Med Surg 1990:73-8

-- 140-

106.. Cooley DA. Frazier OH„ Kadipasaoglu KA, Pehlivanoglu S, Shannon RL. Angelini P. Transmyocardiall laser revascularization. Anatomie evidence of long-term channel patency.. Tex Heart IJ 1994;21:220-4

107.. Dedic K, Klima T, Cooley DA. Frazier OH, Kadipasaoglu KA, Cihan HB. Transmyocardiall laser revascularization - hislopathological findings, Cardiovasc PatholPathol 1998;7:63-7

108.. LutterG, Schwarzkopf J. Lutz C, Martin J, Beyersdorf F. Histologic findings of transmyocardiall laser channels after two hours. Ann Thorac Surg 1998;65:1437-9

109.. Horvalh KA, Aranki SF. Cohn LH, March RJ, Frazier OH. Kadinasaogh! KA, Boyce SW.. Lytle BW, Landolfo KP, Lowe JE. Hauler B, Griffith BP, Lansing AM. Sustained anginaa relief 5 years after transmyocardial laser revascularization with a CO? laser. CirculationCirculation 2001;104:181-4

11 10. Lee LY, O'Hara MF, Finnin EB, Hachamovitch R, Szulc M, Kligfield PD, Okin PM. Isomm OW, Rosengart TK. Transmyocardial laser revascularization with excimcr laser: Clinicall results at 1 year. Ann Thorac Surg 2000;70:498-503

111.. Kavanagh GJ. Whittaker P. Prejean CA, Firth BR, Kloner RA, Kay GL. Dissociation betweenn improvement in angina pectoris and myocardial perfusion after transmyocardiall revascularization with an excimer laser. Am J Cardiol 2001 ;87:229-31

112.. Spertus JA, Winder AJ, Dewhurst TA, Deyo RA, Prodzinski J. McDonell M, Fihn SD. Developmentt and evaluation of the Seattle Angina Questionnaire: A new functional statuss measure for coronary artery disease. J Am Coll Cardiol 1995;25:333-41

113.. Buxton M, Rabin R, Pekurinen M, Bonsel G, Bjork S, Kind P, Nord E. EuroQol - a neww facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208 8

114.. DePuey EG. Updated imaging guidelines for nuclear cardiology procedures, part 1. J NudCardioiNudCardioi 200l$:G\-5&

115.. Germano G, Kavanagh PB, Waechter P, Areeda J, Van Kriekinge S, Sharir T, Lewin HC,, Berman DS. A new algorithm for the quantitation of myocardial perfusion SPECT.. I: Technical principles and reproducibility. J Nucl Med 2000;41:712-9

116.. Jaques S, Tobes MC. Sisson JC, Baker JA, Wieland DM. Comparison of the sodium dependencyy of uptake of meta-iodobenzylguanidine and norepinephrine into cultured bovinee adrenomedullary cells. Mol Pharmacol 1984;26:539-46

117.. Stevens MJ, Raffel DM, Altman KC, Dayanikli F, Ficaro E, Sandford T, Wieland DM, Pfeiferr MA. Schwaiger M. Cardiac sympathetic dysinnervation in diabetes: Implicationss for enhanced cardiovascular risk. Circulation 1998;98:961-8

118.. Yamamoto N. Gu AG. Derosa CM, Shimizu J, Zwas DR. Smith CR, Burkhoff D. Radioo frequency transmyocardial revascularization enhances angiogenesis and causes myocardiall denervation in a canine model. Lasers Surg Med 20Q0;27:18-28

119.. Minisi AJ, Topaz O, Quinn MS, Mohanty LB. Cardiac nociceptive reflexes after transmyocardiall laser revascularization: Implications for the neural hypothesis of anginaa relief. J Thorac Cardiovasc Surg 2001;122:712-9

120.. Hirsch GM, Thompson GW, Arora RC, Hirsch KJ, Sullivan JA, Armour JA. Transmyocardiall laser revascularization does not denervate the canine heart. Ann ThoracThorac Surg 1999;68:460-8

121.. Arora RC, Hirsch GM, Hirsch KJ. Armour A. Transmyocardial laser revascularization remodelss the intrinsic cardiac nervous system in a chronic setting. Circulation 2001;104:1115-20 0

-- 141 -

ReferencesReferences _ ^ — _ 122.. Johnson LL, Thambar S, Donahay T, Dae M. Williams DO. Effect of endomyocardial

laserr channels on regional innervation shown with '""̂ I-MIB G and autoradiography. J Kite/Kite/ Med2002;43:551-5

123.. Stone GW. Teirstein PS, Rubenstein R, Schmidt D, Whitlow PL, Kosinski EJ, Mishkel G.. Power JA. A prospective, multicenter. randomized trial of percutaneous transmyoeardiall laser revascularization in patients with nonrecanalizable chronic total occlusions.. J Am Coll Cardiol 2002:39:1581-7

124.. Zipes DP. Influence of myocardial ischemia and infarction on autonomic innervation off heart. Circulation 1990;82:1095-105

125.. Higgins TL. Estaianous FG. Loop FD. Beck GJ, Blum JM, Paranandi L. Stratification off morbidity and mortality outcome by pre operative risk factors in coronary artery bypasss patients: A clinical severity score. J Am Med Assoc 1992;267:2344-8

126.. Klein M, Dauben HP, Schulte HD, Gams E. Transmyoeardial laser revascularisation: Clinicall observations concerning the use of an excimer laser system. In: Transmyoeardiall laser revascularisation; Management of coronary artery diseases. Kleinn M, Schulte HD and Gams E. Eds. Springer, Berlin. 1998

127.. Morgan IS, Campanella C. Transmyoeardial laser revascularisation in Edinburgh. In: Transmyoeardiall laser revascularisation; Management of coronary artery diseases. Kleinn M. Schulte HD and Gams E, Eds. Springer, Berlin, 1998

128.. Ware JE, Sherboume CD, The MOS 36-item short-form health survey (SF-36). 1: Conceptuall framework and item selection. Med Care 1992;30:473-83

129.. Kiebzak GM, Pierson LM, Campbell M, Cook JW. Use of the SF36 general health statuss survey to document health-related quality of life in patients with coronary artery disease:: effect of disease and response to coronary artery bypass graft surgery. Heart LungLung 2002;31:207-13

130.. Oesterle SN, Sanborn TA. Ali N, Resar J, Ramee SR, Heuser R, Dean L, Knopf W, Schofieldd P, Schaer GL, Reeder G, Masden R, Yeung AC. Percutaneous transmyoeardiall laser revascularisation for severe angina: The PACIFIC randomised trial.. Lancet 2000;356:1705-10

131.. Burns SM, Sharpies LD. Tait S, Caine N, Wallwork J. Schofield PM. The transmyoeardiall laser revascularization international registry report. Eur Heart J 1999;20:31-7 7

132.. Vincent JG, Bardos P, Kruse J, Maass D. End stage coronary disease treated with the transmyoeardiall CO: laser revascularisation: A chance for the 'inoperable' patient. Eur JJ Cardiothorac Surg 1997; 11:888-94

133.. Mantel N. Haenszel W. Statistical aspects of the analysis of data from retrospective studiess of disease. JAW Cancer Inst 1959;22:719-48

134.. Epidemiologic research. Principles and quantitative methods. Kleinbaum DG. Kupper LL.. Morgenstern IL Eds. Lifetime Learning Publications, Belmont. 1982

135.. Okada M, Ikuta H, Shimizu OK, Horii H. Nakamura K. Alternative method of myocardiall revascularization by laser: Experimental and clinical study. Kobe J Med Sci 1986;32:151-61 1

136.. Horvath KA, Cohn LH, Cooley DA, Crew JR, Frazier OH, Griffith BP, Kadipasaoglu K.. Lansing A, Mannting F, March R, Mirhoseini MR, Smith C. Transmyoeardial laser revascularization:: Results of a multicenter trial with transmyoeardial laser revascularizationn used as sole therapy for end-stage coronary artery disease.J Thorac Carctiova.seCarctiova.se Surg ] 997; 113:645-53

-- 142-

137.. Nagelc H. Stubbe HM, Nienabcr C. Rodiger W. Results of transmyocardial laser revascularizationn in non-revascularizable coronary artery disease after 3 years follow-up.. Eur Heart J 1998:19:1525-30

138.. Agarwal R. Aji t M, Kurian VM, Rajan S, Arumugam SB, Cherian KM. Transmyocardiall laser revascularization: Early results and 1 -year follow-up. Ann ThoracSurgThoracSurg 1999;67:432-6

139.. Donovan CL, Landolfo KP, Hughes C, Coleman RB, Lowe JE. Intermediate clinical outcomee following transmyocardial laser revascularization for end-stage coronary arteryy disease. Circulation 1998;98:2850

140.. Hughes GC. Landolfo KP, Lowe JE, Coleman RB, Donovan CL. Perioperative morbidityy and mortality alter transmyocardial laser revascularization: Incidence and riskk factors for adverse events. J Am Coll Cardiol 1999;33:1021-6

!! 41. Lutter G, Sarai K, Nitzschc E. Saurbier B, Frey M. 1 loegerle S, Zipfell M, Spillner G, Beyersdorff F. Evaluation of transmyocardial laser revascularization by following objectivee parameters of perfusion and ventricular function. Thorac Cardiovasc Surg 2000;48:79-85 5

142.. Krabatsch T. Petzina R, Hausmann H, Koster A, Hetzer R. Factors influencing results andd outcome after transmyocardial laser revascularization. Ann Thorac Surg 2002:73:1888-92 2

143.. BrunnerM, Hess B, Lutter G, Zipfel M, Grom A, Beyersdorf F, Bode C, Zehender M. Transmyocardiall laser revascularization and left ventricular reduction surgery affect ventricularr arrhythmias and heart rate variability. Am Heart J 2002;143:1012-6

144.. March RJ, Guynn T. Cardiac allograft vasculopathy: The potential role for transmyocardiall laser revascularization. J Heart Lung Transpl 1995; 14:S242-S246

145.. Frazier OH, Cooley DA, Kadipasaoglu KA, Pehlivanoglu S, Lindenmcir M, Barasch E,, Conger JL, Wilansky S, Moore WH. Myocardial revascularization with laser. Preliminaryy findings. Circulation 1995;92:1158-1165

146.. Donovan CL, Landolfo KP, Lowee JE, Clements F, Coleman RB, Ryan T. Improvementt in inducible ischemia during dobutamine stress echocardiography after transmyocardiall laser revascularization in patients with refractory angina pectoris. J AmAm Co!/ Cardiol 1997;30:607-12

147.. Gassier N, Stubbe HM. Clinical data and histological features of transmyocardial revascularizationn with COvlaser. Eur J Cardiolhorac Surg 1997;12:25-30

148.. Hattler BG. Griffith BP, Zenati MA, Crew JR, Mirhoseim M, Cohn LH, Aranki SF, Frazierr OH, Cooley DA, Lansing AM, Horvath KA, Fontana GP, Landolfo KP, Lowe JE,, Boyce SW. Transmyocardial laser revascularization in the patient with unmanageablee unstable angina. Ann ThoracSurg 1999;68:1203-9

149.. Hughes GC, Landolfo KP. Lowe JE, Coleman RB, Donovan CL. Diagnosis, incidence, andd clinical significance of early postoperative ischemia after transmyocardial laser revascularization.. Am Heart J 1999; 137:1163-8

150.. Dowling RD, Petracek MR, Sellinger SL. Allen KB. Transmyocardial revascularizationn with a holmium laser in patients with refractory angina who are unstable.. Circulation 1997;96:1358

151.. Milano A, Pratali S, Tartarini G, Mariotti R, Decarlo M, Paterni G, Boni G, Bortolotti U.. Early results of transmyocardial revascularization with a holmium laser. Ann ThoracThorac Surg 1998;65:700-4

-- 143-

ReferencesReferences . „ 152.. De Carlo M. Milano AD. Pratali S, Levantino M, Mariotti R. Bortolotti U.

Symptomaticc improvement after trans myocardial laser revascularization: How long doess it last? Ann Thorac Surg 2000:70:1! 30-3

153.. Sundt TM. Mohr FW. Seitelberger R, Smith CR. Robbins RC. Kvemebo K. Burkhoff D.. Transmyoeardiai revascularization with a Ho:YAG laser: Results of 3- and 6-month follow-up.. Circulation 1997;96:3155

11 54. Sundt TM, Kwong KF. Clinical experience with the holmium:YAG laser for transmyoeardiaii laser revascularization and myocardial denervation as a mechanism. SeminSemin Thorac Cardiovasc Surg 1999; 11:19-23

155.. Diegeler A. Schneider J. Lauer B, Mohr FW, Kluge R. Transmyoeardiai laser revascularizationn using the Holium-YAG laser for treatment of end stage coronary arteryy disease. Eur J Cardiothorac Surg 1998;13:392-7

156.. Schneider J. Diegeler A, Krakor R. Walther T, Kluge R, Mohr FW. Transmyoeardiai laserr revascularization with the holmium:YAG laser: Loss of symptomatic improvementt after 2 years. Eur J Cardiothorac Surg 2001; 19:164-9

157.. Guleserian KJ. Maniar HS, Camillo CJ. Baily MS, Damiano Jr RJ, Moon MR. Quality off life and survival after transmyoeardiai laser revascularization with the holmium:YAGG laser. Ann Thorac Surg 2003;75:1842-7

158.. Krabatsch T, Dörschel K. Tülsner J. Transmyoeardiai laser revascularisation - initial resultss in treating diffuse coronary disease. Lasermedizin 1995;11:192-8

159.. Morgan IS, Campanella C. Clinical feature article; Transmyoeardiai laser revascularisationn in Edinburgh. Br J Theat Nurs 1998;7:4-9

160.. Aaberge L. Rootwelt K, Blomhoff S, Saatvedt K., Abdelnoor M, Forfang K. Continued symptomaticc improvement three to five years after transmyoeardiai revascularization withh C02 laser - A late clinical follow-up of the Norwegian randomized trial with transmyoeardiaii revascularization. J Am Co!! Cardiol 2002;39:1588-93

161.. Weintraub WS. Jones EL, Craver JM, Grosswald R. Guyton RA. In-hospital and long-termm outcome after reoperative coronary artery bypass graft surgery. Circulation 1995:922 (Suppl Il):50-7

162.. iskander S. Iskandrian AE. Risk assessment using single-photon emission computed tomographicc technetium-99m sestamibi imaging. J Am Col! Cardiol 1998;32:57-62

163.. Hachamovitch R. Bcrman DS, Kiat 11, Cohen I, Cabico J A, Friedman J, Diamond GA. Exercisee myocardial perfusion SPECT in patients without known coronary artery disease: Incrementall prognostic value and use in risk stratification. Circulation 1996;93:905-14

164.. Hachamovitch R. Berman DS. Shaw LJ, Kiat H, Cohen I, Cabico J A, Friedman J, Diamondd GA. Incremental prognostic value of myocardial perfusion single photon emissionn computed tomography for the prediction of cardiac death: Differential stratificationn for risk of cardiac death and myocardial infarction. Circulation 1998;97:535-43 3

165.. Sharir T. Germano G, Kang X, Lewin HC, Miranda R. Cohen I. Agafitei RD, Friedmann JD, Berman DS. Prediction of myocardial infarction versus cardiac death by gatedd myocardial perfusion SPECT: Risk stratification by the amount of stress-induced ischemiaa and the poststress ejection fraction. J Nucl AW 2001;42:831-7

166.. Sharir T, Germano G, Kavanagh PB. Lai ST, Cohen I. Lewin \\C, Friedman J, Zellwegerr MJ, Berman DS. Incremental prognostic value of post-stress left ventricular ejectionn fraction and volume by gated myocardial perfusion single photon emission computedd tomography. Circulation 1999;100:1035-42

-- 144-

167.. Romanenes M. Gradel C. Saner H, Pfisterer M. Comparison of 99mTc-sestamibi lung/heartt ratio, transient ischaemic dilation and perfusion defect size for the identificationn of severe and extensive coronary artery disease. Eur J NucI Med 2001;28:907-10 0

168.. Fleischmann K.E, Hunink MOM. Kuntz KM, Douglas PS. Exercise echocardiography orr exercise SPECT imaging?: A meta-analysis of diagnostic test performance. J Am MedMed Assoc 1998;280:913-20

169.. Maddahi J, Rodriques E, Kiat H, Van Train KF, Berman DS. Detection and evaluation off coronary artery disease by Thallium-201 myocardial perfusion scintigraphy. In: Lardiacc SPECT imaging. DePuey EG, Berman DS and Garcia EV, Eds. Raven Press Ltd,, New York. 1995

170.. Iskandrian AS, Heo J, Kong B, Lyons E. Effect of exercise level on the ability of thallium-2011 tomographic imaging in detecting coronary artery disease: Analysis of 4611 patients. J Am Coll Cardiol 1989;14:1477-86

171.. Tamaki N. Yonekura Y, Mukai T, Kodama S, Kadota K, Kambara H, Kawai C, Torizukaa K. Stress thallium-201 transaxial emission computed tomography: quantitativee versus qualitative analysis for evaluation of coronary arterv disease. J Am CollColl Cardiol 1984;4:1221

172.. Berthe C, Pierard LE, Hiernaux M, Trotteur G. Lempereur P, Carlier J, Kulbertus H. Predictingg the extent and location of coronary artery disease in acute myocardial infarctionn by echocardiography during dobutamine infusion. Am J Cardiol 1986;58:1167-72 2

173.. Segar DS, Brown SE, Sawada SG, Ryan T, Feigenbaum H. Dobutamine stress echocardiography:: Correlation with coronary lesion severity as determined by quantitativee angiography. J^m Coll Cardiol 1992;19:1197-202

174.. Marcovitz PA, Armstrong WF. Accuracy of dobutamine stress echocardiography in detectingg coronary artery disease. Am J Cardiol 1992;69:1269-73

175.. Aarnoudse WH, Botman KJ, Pijls NH. False-negative myocardial scintigraphy in balancedd three-vessel disease, revealed by coronary pressure measurement, lm J CardiovascCardiovasc Intervent 2003;5:71

176.. Huikeshoven M, van der Sloot JAP, Tukkie R, van Gemert MJC. Tijssen JGP, Beek JF.. Improved quality of life after XeCI excimer transmyocardial laser revascularisation:: Results of a randomised trial. Lasers Surg Med 2003;33:1-7

177.. Gray TJ. Bums SM, Clarke SC, Tait S, Sharpies LD, Caine N, Schofield P. Percutaneouss myocardial laser revascularization in patients with refractory angina pectoris.. Am J Cardiol 2003:91:661-6

178.. Markos J, Mullan BP, Hillman DR, Musk AW, Antico VF. Lovegrove FT, Carter MJ, Finucanee KE. Preoperative assessment as a predictor of mortality and morbidity after lungg resection. Am Rev Respir Dis 1989;139:902-10

179.. Bolliger CT, Wyser C, Roser H, Soler M, Perruchoud AP. Lung scanning and exercise testingg for the prediction of postoperative performance in lung resection candidates at increasedd risk for complications. Chest 1995;108:341-8

-- 145-